Free. Unsubscribe any time.
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS filed 8 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 23 transactions and 56,805 shares. 8 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-02, came 14 days after the one before it (2026-06-18) and reports 1 transaction against 4 in the filing before it.
- The sales it reports total 5,681 shares, 14,319 fewer than the 20,000 in the filing before it.
- Its 8 plan statements rank 404th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 5 have more plan statements on file than it and 5 have fewer.
- Its 8 filings on file run from 2025-09-04 to 2026-07-02, and state 2 plan adoption dates, from 2025-05-16 to 2026-03-13.
Trades in NEKTAR THERAPEUTICS 23
- ROBIN HOWARD W — 2025-09-02 · S · 1,500 shares
- ROBIN HOWARD W — 2025-09-04 · S · 1,923 shares
- ROBIN HOWARD W — 2025-09-04 · S · 1,496 shares
- ROBIN HOWARD W — 2025-09-04 · S · 613 shares
- ROBIN HOWARD W — 2025-09-04 · S · 1,134 shares
- Zalevsky Jonathan — 2025-09-04 · S · 793 shares
- Zalevsky Jonathan — 2025-09-04 · S · 432 shares
- Zalevsky Jonathan — 2025-09-04 · S · 189 shares
- Zalevsky Jonathan — 2025-09-04 · S · 307 shares
- ROBIN HOWARD W — 2025-09-05 · S · 3,304 shares
- ROBIN HOWARD W — 2025-09-05 · S · 2,226 shares
- ROBIN HOWARD W — 2025-09-05 · S · 1,136 shares
Adoption dates in NEKTAR THERAPEUTICS 2
- 2025-05-16 — stated in 1 filing
- 2026-03-13 — stated in 3 filings
Results prints in NEKTAR THERAPEUTICS 7
- 2025-03-12
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-03-12
- 2026-05-07
- 2026-08-13
Trades before a print in NEKTAR THERAPEUTICS 0
- 44 days before the 2026-08-13 print — 2026-06-30 · S · Zalevsky Jonathan · 5,681 shares
- 51 days before the 2026-03-12 print — 2026-01-20 · S · Zalevsky Jonathan · 3,867 shares
- 57 days before the 2026-08-13 print — 2026-06-17 · S · ROBIN HOWARD W · 5,500 shares
- 57 days before the 2026-08-13 print — 2026-06-17 · S · ROBIN HOWARD W · 4,500 shares
- 58 days before the 2025-11-06 print — 2025-09-09 · S · ROBIN HOWARD W · 2,100 shares
- 58 days before the 2025-11-06 print — 2025-09-09 · S · ROBIN HOWARD W · 1,200 shares
- 58 days before the 2025-11-06 print — 2025-09-09 · S · ROBIN HOWARD W · 2,156 shares
- 58 days before the 2025-11-06 print — 2025-09-09 · S · ROBIN HOWARD W · 1,210 shares
- 58 days before the 2026-08-13 print — 2026-06-16 · S · ROBIN HOWARD W · 5,303 shares
- 58 days before the 2026-08-13 print — 2026-06-16 · S · ROBIN HOWARD W · 4,697 shares
- 59 days before the 2026-08-13 print — 2026-06-15 · S · Zalevsky Jonathan · 5,538 shares
- 62 days before the 2025-11-06 print — 2025-09-05 · S · ROBIN HOWARD W · 3,304 shares
Interval to NEKTAR THERAPEUTICS’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 44shortest, days
- 0no later print
Adoption dates NEKTAR THERAPEUTICS states
- 2025-05-16 in 1 filing
- 2026-03-13 in 3 filings
Filing text: “10b5-1 trading plan adopted by the reporting person on May 16, 2025”
Reported results dates on file
- 2025-03-12
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-03-12
- 2026-05-07
- 2026-08-13
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.